CRIS Current Research Information System

PADELLA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.117
EU - Europa 2.559
AS - Asia 1.650
AF - Africa 220
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
SA - Sud America 7
Totale 7.569
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.102
VN - Vietnam 865
GB - Regno Unito 829
SE - Svezia 445
CN - Cina 367
IT - Italia 367
DE - Germania 294
SG - Singapore 187
IN - India 135
IE - Irlanda 125
FR - Francia 108
TG - Togo 81
RU - Federazione Russa 74
EE - Estonia 62
ZA - Sudafrica 60
BG - Bulgaria 52
CH - Svizzera 44
UA - Ucraina 44
NG - Nigeria 40
CI - Costa d'Avorio 39
FI - Finlandia 38
BE - Belgio 37
JO - Giordania 34
CA - Canada 15
IR - Iran 15
GR - Grecia 13
UZ - Uzbekistan 9
EU - Europa 8
JP - Giappone 5
AU - Australia 4
ES - Italia 4
HR - Croazia 4
ID - Indonesia 4
KR - Corea 4
MK - Macedonia 4
NL - Olanda 4
AT - Austria 3
NZ - Nuova Zelanda 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BR - Brasile 2
CL - Cile 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AZ - Azerbaigian 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 7.569
Salva come PNG Salva come JPEG
Città #
Southend 789
Dong Ket 684
Chandler 411
Fairfield 288
Ann Arbor 277
Ashburn 222
Houston 189
Wilmington 165
Singapore 157
Seattle 147
Woodbridge 147
Princeton 126
Dublin 124
Cambridge 115
Beijing 100
Bologna 81
Lomé 81
Nanjing 62
Westminster 62
New York 61
Padova 60
Medford 58
Sofia 52
Abeokuta 40
Abidjan 39
Boardman 37
Bern 36
Brussels 36
Santa Clara 35
Amman 34
Berlin 31
Bremen 29
Redwood City 29
Saint Petersburg 27
Hebei 26
Turin 24
Helsinki 23
Changsha 21
Jinan 20
Nanchang 20
Shenyang 20
Jiaxing 19
Redmond 19
Los Angeles 16
Mountain View 16
Paris 16
Florence 15
Lappeenranta 15
Milan 15
San Diego 15
Norwalk 12
Falls Church 11
Toronto 10
Hangzhou 8
Haikou 7
Monmouth Junction 7
Ningbo 7
Taizhou 7
Tianjin 7
Athens 6
Guangzhou 6
Leawood 6
London 6
Romainville 6
Rome 6
Augusta 5
Bo 5
Dearborn 5
Forlì 5
Bitola 4
Busseto 4
Bühl 4
Hyderabad 4
Jakarta 4
Muizenberg 4
Napoli 4
Phoenix 4
Zanjan 4
Andover 3
Chengdu 3
Fremont 3
Lanzhou 3
Lugo 3
Pune 3
Reggio Emilia 3
Riva 3
San Francisco 3
San Mateo 3
Taiyuan 3
Tokyo 3
Vienna 3
Zhengzhou 3
Zurich 3
Almaty 2
Amsterdam 2
Ardabil 2
Arosio 2
Auckland 2
Bagnacavallo 2
Bishkek 2
Totale 5.358
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 278
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 230
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 225
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 210
Alterations in phosphatidylinositol 3-phosphate (PI3P) pathway and cAMP pathway confirm poor prognosis and reduced overall survival (OS) in a series of 209 acute myeloid leukemia patients 190
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 187
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 185
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 183
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 174
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 169
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 167
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 164
Chromothripsis in AML patients: A new mechanism of cancer initiation and progression 159
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 154
Clustering Adult ACUTE Lymphoblastic Leukemia (ALL) Philadelphia Negative (Ph-) By Whole Exome Sequencing (WES) Analysis 150
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 144
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 143
Clec12a: A new AML stem cell-associated antigen 131
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 127
Fanconi anemia gene variants in therapy-related myeloid neoplasms 126
Ex-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform 125
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 125
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 123
An analysis pipeline for variant discovery in Whole Exome Sequencing data of cancer samples. 119
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 118
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 118
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 117
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 117
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 117
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 116
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 115
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 114
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 113
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 112
Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis 110
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 109
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia 106
SNP array reveals a new deletion of JAK2 in AML patients 105
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 103
A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 103
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 102
You have accessEx-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform 101
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 97
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 92
Novel fusion transcripts identified by RNAseq cooperate with somatic mutations in the pathogenesis of acute myeloid leukemia 89
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 88
Override the doxorubicin-induced G2/M checkpoint using cell-cycle checkpoint inhibitors on acute lymphoblastic leukemia 87
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 87
A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination 87
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 87
Genomic wide microarray analysis identifies novel copy number alterations in adult acute myeloid leukemia 87
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 86
Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia 85
You have accessA New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 84
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 81
Gene expression signature of aneuploidy in acute myeloid leukemia 80
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 80
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 78
Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia 78
New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patients 78
You have accessMine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic Drugs 77
Pharmacological interaction and side effects in oncohaematology: a retrospective observational study 74
Aneuploidy: Cancer strength or vulnerability? 70
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin 21
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 20
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies 13
Totale 7.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.224 0 0 2 84 159 124 175 179 217 124 103 57
2020/20211.591 159 38 21 19 32 76 48 96 105 51 81 865
2021/20221.468 171 44 79 142 154 80 41 80 79 87 275 236
2022/20231.682 189 240 98 227 120 131 54 72 286 46 138 81
2023/2024464 16 62 22 49 31 138 28 39 25 29 10 15
2024/2025353 37 256 60 0 0 0 0 0 0 0 0 0
Totale 7.790